Skip to main content
. 2015 Oct 6;5(10):e652. doi: 10.1038/tp.2015.135

Figure 1.

Figure 1

Differences in the fecal microbial communities in chronic risperidone (RSP)-treated participants vs psychiatric controls. PcoA of unweighted UniFrac distances between psychiatric control participants (green), chronic RSP-treated participants with significant body mass index (BMI) gain (blue, i.e., an increase in age−sex-specific BMI Z-score⩾0.5 units since starting RSP), and RSP-treated participants without significant BMI gain (yellow). Each point shows the average distance between individuals. Results are derived from bacterial V1−V2 16S rRNA data sets. ANOSIM R=0.5169, P=0.0001. PCoA, principal component analysis.